Chemical-structure (Image 01)
Varenicline Tablet, Film Coated
Product Images NDC 75834-334
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 75834-334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nivagen Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-1 (Image 02)
Figure-2 (Image 03)
Figure-3 (Image 04)
This text seems to be a schedule detailing a study or experiment comparing the effects of Varenicline Tablets 1.0 mg twice a day and a placebo. The study appears to be tracking abstinence rates over time up to 40 weeks with nontreatment follow-up at 48 and 52 weeks.*
Image-05.jpg (Image 05)
Image-06.jpg (Image 06)
Image-07.jpg (Image 07)
This is a description of Varenicline tablets with a dosage strength of 0.5 mg. Each tablet is to be stored at controlled room temperature and dispensed in its original blister packaging. The medication guide is to be provided to each patient. The tablets are dispensed in a pack of 56 tablets by NIVAGEN. The information also includes a coating-free area for serialization data such as expiration date and lot number.*
Image-08.jpg (Image 08)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
